Shiema Abdalla
Hamad Medical Corporation(QA)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Hepatitis C virus research, COVID-19 and healthcare impacts
Most-Cited Works
- → Tocilizumab for the treatment of severe coronavirus disease 2019(2020)268 cited
- → The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study(2020)55 cited
- → Fatal Coronavirus Disease 2019-associated Pulmonary Aspergillosis; A Report of Two Cases and Review of the Literature(2020)25 cited
- → The First Consecutive 5000 Patients with COVID-19 in Qatar; a Nation-wide Cohort Study(2020)9 cited
- → Dilemma of Tocilizumab therapy for a patient with critical COVID‐19 disease and neutropenia: Case report and review of the literature(2022)3 cited
- → Acute Kidney Injury Caused by Darunavir in a Patient with COVID-19: A Case Report(2020)1 cited
- → Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study(2022)
- → The dilemma of Tocilizumab therapy for a patient with critical COVID-19 disease and neutropenia: Case report and review of the literature(2022)
- → Favipiravir for the Treatment of Coronavirus Disease 2019; a propensity score-matched cohort study(2021)